A detailed history of China Universal Asset Management Co., Ltd. transactions in Sanofi stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 52,642 shares of SNY stock, worth $2.57 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
52,642
Previous 52,642 -0.0%
Holding current value
$2.57 Million
Previous $2.56 Million -0.0%
% of portfolio
0.33%
Previous 0.33%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$45.75 - $52.48 $923,509 - $1.06 Million
20,186 Added 62.19%
52,642 $2.56 Million
Q4 2023

May 21, 2024

SELL
$43.13 - $54.79 $870,622 - $1.11 Million
-20,186 Reduced 38.35%
32,456 $1.61 Million
Q4 2023

Jan 23, 2024

BUY
$43.13 - $54.79 $1.09 Million - $1.38 Million
25,213 Added 348.1%
32,456 $1.61 Million
Q3 2023

May 21, 2024

BUY
$50.95 - $55.2 $169,459 - $183,595
3,326 Added 84.91%
7,243 $388,000
Q3 2023

Oct 30, 2023

BUY
$50.95 - $55.2 $169,459 - $183,595
3,326 Added 84.91%
7,243 $389,000
Q2 2023

May 21, 2024

SELL
$50.45 - $57.18 $5,499 - $6,232
-109 Reduced 2.71%
3,917 $211,000
Q2 2023

Jul 27, 2023

SELL
$50.45 - $57.18 $5,499 - $6,232
-109 Reduced 2.71%
3,917 $211,000
Q1 2023

May 21, 2024

BUY
$45.86 - $54.45 $50,033 - $59,404
1,091 Added 37.17%
4,026 $219,000
Q1 2023

Apr 27, 2023

BUY
$45.86 - $54.45 $50,033 - $59,404
1,091 Added 37.17%
4,026 $219,000
Q4 2022

May 21, 2024

SELL
$38.86 - $48.55 $1.93 Million - $2.41 Million
-49,707 Reduced 94.42%
2,935 $142,000
Q4 2022

Jan 31, 2023

BUY
$38.86 - $48.55 $8,199 - $10,244
211 Added 7.75%
2,935 $142,000
Q3 2022

Oct 21, 2022

BUY
$37.22 - $100.5 $101,387 - $273,762
2,724 New
2,724 $104,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $123B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.